VE

Vijith Erumpuzhi Kalarikkal

Active Director Designated Partner DIN 08391758
DIN 08391758 First appointment Mar 2019 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijith Erumpuzhi Kalarikkal

Data last updated:

Vijith Erumpuzhi Kalarikkal is a Designated Partner at Calicuteyes Eyecare Llp (since 2019). The company operates in Healthcare.

DIN 08391758
Primary Designation Designated Partner
Industry Healthcare
First Appointment 27 Mar 2019
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Mar 20192015Active

Board colleagues of Vijith Erumpuzhi Kalarikkal

NameDINCompanyDesignation
Hemakumari Mundamthatam Kalirikkal09293117Calicuteyes Eyecare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Calicuteyes Eyecare Llp
Premium access

Shareholding and investment profile for Vijith Erumpuzhi Kalarikkal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijith Erumpuzhi Kalarikkal

Vijith Erumpuzhi Kalarikkal currently holds 1 directorship: Calicuteyes Eyecare Llp (Designated Partner, since 27 Mar 2019).

Vijith Erumpuzhi Kalarikkal was first appointed on 27 Mar 2019 as Designated Partner at Calicuteyes Eyecare Llp.

The current boards of Vijith Erumpuzhi Kalarikkal's companies include Hemakumari Mundamthatam Kalirikkal (Calicuteyes Eyecare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available